HN2001000038A - CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE - Google Patents
CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINEInfo
- Publication number
- HN2001000038A HN2001000038A HN2001000038A HN2001000038A HN2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A HN 2001000038 A HN2001000038 A HN 2001000038A
- Authority
- HN
- Honduras
- Prior art keywords
- agent
- ciprofloxacine
- oral administration
- administration system
- daily intake
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
El presente invento se relaciona con un compuesto farmaceutico que viene en forma de tabletas o capsulas, y que proporciona una combinacion de control especial y temporal para la administración del medicamento, especificamente del fármaco:CIPROFLOXACINA a un paciente para obtener resultados terapéuticos efectivos. el compuesto farmaceutico comprende:CIPROFLOXACINA, un componente que genera gas (efervecencia), un agente de expansión y por lo menos otro agente que puede ser un agente viscolizante o un agente de gelación (gel).El agente de expansión pertenece a una clase de compuestos altamente absorbentes a los ya comúnmente se les conoce como super-desintegrantes.The present invention relates to a pharmaceutical compound that comes in the form of tablets or capsules, and that provides a combination of special and temporary control for the administration of the drug, specifically the drug: CIPROFLOXACIN to a patient to obtain effective therapeutic results. The pharmaceutical compound comprises: CIPROFLOXACIN, a component that generates gas (effervescence), a blowing agent and at least one other agent that can be a viscolizing agent or a gelling agent (gel). highly absorbent compounds are now commonly known as super-disintegrants.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51788700A | 2000-03-03 | 2000-03-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HN2001000038A true HN2001000038A (en) | 2005-03-23 |
Family
ID=24061635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HN2001000038A HN2001000038A (en) | 2000-03-03 | 2001-03-02 | CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP1263409A1 (en) |
| JP (1) | JP2003525229A (en) |
| KR (1) | KR20030009374A (en) |
| CN (1) | CN1420763A (en) |
| AP (2) | AP2001002084A0 (en) |
| AR (1) | AR032614A1 (en) |
| AU (1) | AU3589701A (en) |
| BG (1) | BG107055A (en) |
| BR (1) | BR0108958A (en) |
| CA (1) | CA2400950A1 (en) |
| CZ (1) | CZ20022883A3 (en) |
| DO (1) | DOP2001000130A (en) |
| EA (1) | EA200200914A1 (en) |
| EC (1) | ECSP013952A (en) |
| EE (1) | EE200200497A (en) |
| GT (1) | GT200100033A (en) |
| HN (1) | HN2001000038A (en) |
| HR (1) | HRP20020715A2 (en) |
| HU (1) | HUP0204417A3 (en) |
| IL (1) | IL151553A0 (en) |
| IS (1) | IS6532A (en) |
| MX (1) | MXPA02008568A (en) |
| NO (1) | NO20024108L (en) |
| NZ (1) | NZ520927A (en) |
| OA (1) | OA12381A (en) |
| PE (1) | PE20011113A1 (en) |
| PL (1) | PL365071A1 (en) |
| SK (1) | SK12542002A3 (en) |
| WO (1) | WO2001064183A1 (en) |
| YU (1) | YU66202A (en) |
| ZA (1) | ZA200206764B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
| US20030229101A1 (en) * | 2002-06-06 | 2003-12-11 | Sherman Bernard Charles | Tablets comprising ciprofloxacin hydrochloride |
| DE10351448A1 (en) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Flavor-containing drug formulations with improved pharmaceutical properties |
| DE602005007205D1 (en) * | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive compositions and methods of preparation |
| ATE460934T1 (en) * | 2006-07-19 | 2010-04-15 | Tabuk Pharmaceutical Mfg Co | PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN |
| US10363288B2 (en) | 2015-01-14 | 2019-07-30 | National Jewish Health | Insulin mimotopes and methods of using the same |
| EP3419669A4 (en) * | 2016-02-23 | 2019-10-30 | Matripharm International Inc. | Dual-rate release formulation with high drug loading |
| US9820957B2 (en) | 2016-03-24 | 2017-11-21 | The Regents Of The University Of Colorado, A Body Corporate | Methods of treating autoimmunity |
| US11052060B2 (en) | 2018-02-12 | 2021-07-06 | The Regents Of The University Of Colorado, A Body Corporate | Compounds and methods for treating autoimmunity |
| US11013707B2 (en) | 2018-03-23 | 2021-05-25 | The Regents Of The University Of Colorado, A Body Corporate | Administration of oral methyldopa |
| CN109806237A (en) * | 2019-03-13 | 2019-05-28 | 悦康药业集团上海制药有限公司 | A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5096714A (en) * | 1988-06-28 | 1992-03-17 | Hauser-Kuhrts, Inc. | Prolonged release drug tablet formulations |
| JPH0624959A (en) * | 1991-10-04 | 1994-02-01 | Bayer Yakuhin Kk | Medice release solid pharmaceutical preparation of gastric suspending type sustained |
| DE4406424A1 (en) * | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandable dosage forms |
| DE19839057A1 (en) * | 1998-08-28 | 2000-03-02 | Koch Berthold | Purge air controller for a drying device for compressed air |
| DK1107741T3 (en) * | 1998-09-14 | 2003-11-17 | Ranbaxy Lab Ltd | Orally administered regulated management system providing temporal and spatial regulation |
-
2001
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 IL IL15155301A patent/IL151553A0/en unknown
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/en not_active Application Discontinuation
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/en unknown
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/en unknown
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/en unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/en active Pending
- 2001-02-28 EE EEP200200497A patent/EE200200497A/en unknown
- 2001-02-28 PL PL01365071A patent/PL365071A1/en not_active Application Discontinuation
- 2001-02-28 NZ NZ520927A patent/NZ520927A/en unknown
- 2001-02-28 EA EA200200914A patent/EA200200914A1/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/en unknown
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/en not_active Withdrawn
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 YU YU66202A patent/YU66202A/en unknown
- 2001-02-28 AR ARP010100957A patent/AR032614A1/en not_active Application Discontinuation
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/en not_active Withdrawn
- 2001-03-01 GT GT200100033A patent/GT200100033A/en unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/en not_active Application Discontinuation
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/en unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/en unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/en unknown
-
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/en unknown
- 2002-08-30 HR HRP20020715 patent/HRP20020715A2/en not_active Application Discontinuation
- 2002-09-02 BG BG107055A patent/BG107055A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| OA12381A (en) | 2004-09-06 |
| EP1263409A1 (en) | 2002-12-11 |
| IS6532A (en) | 2002-08-28 |
| ECSP013952A (en) | 2002-04-23 |
| ZA200206764B (en) | 2003-03-04 |
| DOP2001000130A (en) | 2004-03-31 |
| EE200200497A (en) | 2004-02-16 |
| AU3589701A (en) | 2001-09-12 |
| BR0108958A (en) | 2003-09-30 |
| NO20024108L (en) | 2002-10-25 |
| GT200100033A (en) | 2001-10-25 |
| HUP0204417A2 (en) | 2003-05-28 |
| SK12542002A3 (en) | 2003-05-02 |
| NO20024108D0 (en) | 2002-08-28 |
| CN1420763A (en) | 2003-05-28 |
| AP2001002084A0 (en) | 2001-03-31 |
| AP1485A (en) | 2005-10-31 |
| JP2003525229A (en) | 2003-08-26 |
| NZ520927A (en) | 2003-06-30 |
| HRP20020715A2 (en) | 2004-12-31 |
| CA2400950A1 (en) | 2001-09-07 |
| HUP0204417A3 (en) | 2005-03-29 |
| AR032614A1 (en) | 2003-11-19 |
| CZ20022883A3 (en) | 2003-04-16 |
| MXPA02008568A (en) | 2003-02-24 |
| IL151553A0 (en) | 2003-04-10 |
| WO2001064183A1 (en) | 2001-09-07 |
| EA200200914A1 (en) | 2003-02-27 |
| AP2002002627A0 (en) | 2002-09-30 |
| KR20030009374A (en) | 2003-01-29 |
| PL365071A1 (en) | 2004-12-27 |
| PE20011113A1 (en) | 2001-10-14 |
| BG107055A (en) | 2003-06-30 |
| YU66202A (en) | 2005-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR022672A1 (en) | A PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS OR CAPSULES THAT CONSTITUTE AN ORAL ADMINISTRATION METHOD OF A DRUG | |
| AR049985A1 (en) | COMBINATION TREATMENT FOR NON-HEMATOLOGICAL MALIGNAL DISEASES | |
| NO993520L (en) | Dosage forms and methods for better erectile dysfunction | |
| BRPI0517891A (en) | compositions comprising azelastine and methods of use thereof | |
| ES2109899T1 (en) | METHOD, COMPOSITIONS AND KITS TO INCREASE ORAL BIOAVAILABILITY OF PHARMACEUTICAL AGENTS. | |
| GT199900151A (en) | DRUG CONTROLLED DELIVERY SYSTEM ORALALLY ADMINISTERED, PROVIDING TEMPORARY AND SPACE CONTROL. | |
| BR9916224A (en) | Oral pharmaceutical dosage form, processes for the manufacture of a fixed dosage form, for the treatment and prophylaxis of gastrointestinal disorders and to prevent gastrointestinal side effects, use of a dosage form, combination, and ampoule packaging | |
| UY30537A1 (en) | FLIBANSERIN FORMULATIONS AND METHOD TO MANUFACTURE THEM | |
| CR8352A (en) | PHARMACEUTICAL FORMULATIONS, PROCEDURES AND DOSAGE GUIDELINES FOR THE TREATMENT AND PREVENTION OF ACUTE CORONARY SYNDROMES | |
| AR025959A1 (en) | DERIVATIVES OF TER.-BUTIL- (7-METHYL-IMIDAZO [1,2, a] PIRIDIN-3-IL) -AMINA, PROCEDURE FOR THEIR PREPARATION, DRUGS THAT CONTAIN THEM, THEIR USE FOR THE PREPARATION OF A MEDICATION FOR THE INHIBITION OF NON-SYNTHEASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EA200501203A1 (en) | LIQUID PHARMACEUTICAL COMPOSITIONS OF PALONOSETRON | |
| AR022589A1 (en) | A CAPSULE THAT INCLUDES A SPONTANELY DISPERSABLE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION, A SPONTANELY DISPERSABLE PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION AND THE USE FOR THE PREPARATION OF A TREATMENT MEDICATION | |
| UY25544A1 (en) | NEFAZODONE DOSAGE FORM | |
| DE60233898D1 (en) | TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE WITH HIGH ROTIGOTINE PLASMAS MIRRORS | |
| HN2001000038A (en) | CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE | |
| ATE292453T1 (en) | ANTIVIRAL DRUG | |
| ECSP034826A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE | |
| DE50203456D1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS | |
| BR0014826A (en) | Bicyclic imidazo-3-yl-amines, their preparation procedure and medications containing them | |
| BR0013719A (en) | Controlled-release oral dosage, suitable for oral administration | |
| AR036312A1 (en) | PHARMACEUTICAL COMPOSITION | |
| DE60205905D1 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH IMPROVED BIOAVAILABILITY | |
| BR0116060A (en) | Dronedarone pharmaceutical composition for parenteral administration | |
| AR034142A1 (en) | A PHARMACEUTICAL COMPOSITION, METHOD FOR MANUFACTURING A MEDICINAL BASED ON SUCH COMPOSITION AND USE OF THE COMPOSITION | |
| RU2011113733A (en) | Derivatives of 1-amino-alkylcyclohexane for the treatment of cognitive impairment in noise in the ears |